Assignee
SHANGHAI PREC MEDICINE CO LTD
CN·1 granted patent·1 pending application·0 citations·filing 2020–2021
Top patents by PatentIndex Score
2 records- 0139US12553091B2Gene panels for molecular subtype and survival risk assessment of lung adenocarcinoma and diagnostic products and applications thereofSHANGHAI PREC MEDICINE CO LTD·Filed 2020·Granted Feb 17, 2026·0 cites·19 claims
- 0238US2023194531A1Interferon Signaling Pathway-Related Gene Panel, Diagnostic Product and Application ThereofSHANGHAI PREC MEDICINE CO LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SHANGHAI PREC MEDICINE CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →